14Th Global Biomarkers Summit 2018
14th Global Biomarkers Summit (Biomarker Summit 2018)
October 18-19, 2018
Amsterdam, Netherlands
150+ delegates from Global Pharma & Bio Pharma Companies. CROs, hospitals, Biotech firms, renowned institutes, and Universities to participate at this Biomarker Summit. 30+ case studies, presentations, panel discussions, plenary sessions, Poster Presentations, e-Poster Presentations, and Young Researcher Forums will discuss the current trends, issues, and novel discoveries in Biomarker Discovery, Biomarker research, clinical applications of Biomarkers, companion diagnostics, personalized medicine, Clinical & Translational Research in Biomarkers, etc. To encourage Young Researchers across the globe, Global Biomarker Congress is up with the Young Researcher Forum (YRF), Best poster & Oral Presentation Awards, and Young Researcher awards.
This Global Biomarker Summit will address the challenges in Biomarker Discovery to development, Translational Biomarker research Commercialization of Biomarkers. Major sessions of this Biomarker Conference will focus on Biomarker discovery & validation, Next-generation Sequencing (NGS), Biomarkers evaluation, Biomarkers in disease diagnosis & prognosis, Commercialization of Biomarkers, Biomarker approval, Biomarkers in Clinical Trials, Biomarkers in Drug Discovery, Functional genomics and cytogenetic biomarkers, techniques to maximize biomarker identification, biomarkers applications in Nanoscience, challenges of clinical translation, Companion Diagnostics, Reimbursement policy
Biomarkers Summit warmly invites all the experts working in Biomarkers and related fields to its upcoming 14th Global Biomarker Summit (Biomarker Summit 2018), scheduled from October 18-19, 2018 Amsterdam, Netherlands.
Cancer is dangerous owing to its ability to spread around the body.
The impossibility of the fact that all conventional treatment methods for this disease do not, all the known drugs do not have a selective effect: while using traditional methods of cancer treatment not only killed but the healthy cells too. to solve this problem was not successful because all cells have predominantly negative charges, but these have been to be more pronounced in cancer
This finding was the basis for the opment of NSC 631570 (Ukraine). It consists of celandine alkaloid derivatives.
From ancient times Celandine juice has been successfully used for skin diseases. , for example, the Slavic folks used to call it «Ð±Ð¾Ñ€Ð¾Ð´Ð°Ð²Ð¾Ñ‡Ð½Ð¸Ðº» (borodavochnyk - the warthog) and the Germans call it to the wart, then it should disappear in a week. The warts are the same, but only of benign origin., skin cancer gives the Celandine alkaloids the anti-cancer I made it positively ionized.
As a result, the substance accumulates very rapidly in tumor tissue and metastases, which can also be through the fluorescence of the tissue under UV light.
The anti-cancer preparation NSC 631570 (Ukrain) gives grounds to guess that cancer is a curable disease.
This is a new mode of therapy called proton therapy many scientists are devoting themselves to this promising approach.
dctguijbjj gyhijkb hhmkjrvfj cyncj
Article Source: http://EzineArticles.com/9991147